Sector: MedicalWatson Pharmaceuticals, Inc. (NYSE: WPI)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 89 |
Technical : | 165 |
Performance : | 172 |
Overall: | 144 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 87 |
Technical : | 28 |
Performance : | 140 |
Overall: | 25 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 91 |
Technical : | 13 |
Performance : | 120 |
Overall: | 17 |
Number of Stocks: | 305 |
Headlines
- Watson to Present at Credit Suisse Healthcare Conference
Nov 06, 2009 04:00 PM | WPI
- Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona
Nov 04, 2009 08:15 PM | WPI
- Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
Nov 04, 2009 07:30 AM | WPI
- Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand
Oct 30, 2009 07:31 AM | WPI
- Watson and Barr Settle Lawsuit Over Oxytrol(R)
Oct 28, 2009 08:02 AM | WPI
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- Watson to Host Third Quarter 2009 Earnings Conference Call and Webcast
Oct 13, 2009 08:01 AM | WPI
- RidgewaterEquity.com Free Fundamental Sector & Market Research on EXG, WPI, AVY, TTM, RBY and PHK
Oct 09, 2009 06:44 AM | AVY, WPI
- CBI Announces the Agenda for its Forum on FDA's Structured Product Labeling (SPL R4)
Sep 29, 2009 08:15 AM | GENZ, GSK, SNY, WPI, WYE
- New Data Suggest that GELNIQUE(R) (oxybutynin chloride) gel 10% Does Not Impact Cognition among Healthy Older Adults
Sep 29, 2009 07:50 AM | WPI
- Watson Pharmaceuticals Q3 net income down
Nov 06, 2009 03:52 AM | WPI
- Omniture Deal a Milestone for Utah's Tech Sector: The $1.8 Billion Price Tag Would Make It the Largest Such Deal in the State's History.
Sep 16, 2009 01:53 PM | ADBE, ATRS, CEPH, NOVL, OMTR, SYMC
- Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2009
Jul 01, 2009 02:53 PM | AZN, PFE, WPI
- FedEx, Beazer Homes, Netflix are big movers
Jun 17, 2009 05:51 PM | BBI, BZH, ETFC, FDX, NFLX, RAI
- Watson Pharmaceuticals Earnings Stronger Than Expected
May 01, 2009 02:57 PM | WPI
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on EXG, WPI, AVY, TTM, RBY and PHK
Oct 09, 2009 08:14 AM | AVY, RBY, TTM, WPI
- Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents
Sep 10, 2009 04:51 PM | WPI
- Watson Prices $850 Million of Senior Unsecured Notes
Aug 18, 2009 05:10 PM | WPI
- Watson Announces Offering of Senior Unsecured Notes
Aug 18, 2009 09:03 AM | WPI
- Watson Announces Limited Recall Of Fentanyl Transdermal System
Aug 07, 2009 05:02 PM | WPI
- Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
Aug 06, 2009 06:09 PM | WPI
- Stellar Pharmaceuticals Announces Record Second Quarter Revenues and Profitability for the First Half
Aug 05, 2009 07:51 AM | WPI
- Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
Aug 03, 2009 04:00 PM | WPI
- Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
Jul 29, 2009 07:55 AM | TEVA, WPI
- Recordati Signs an Agreement With Nycomed for the Co-Marketing of Silodosin in Italy
Jul 29, 2009 05:51 AM | WPI
- Form 4 JOYCE R TODD For: Oct 30 (10K)
Oct 30, 2009 05:49 PM
- Form 4 Wilkinson George Fred For: Sep 21 (10K)
Sep 22, 2009 06:26 PM
- Form 3 Wilkinson George Fred For: Sep 21 (10K)
Sep 22, 2009 06:25 PM
- Form 4 Mayr Charles M For: Sep 21 (10K)
Sep 22, 2009 06:21 PM
- Form 3 Mayr Charles M For: Sep 21 (10K)
Sep 22, 2009 06:19 PM
- Form 4 BISARO PAUL For: Sep 04 (10K)
Sep 08, 2009 06:25 PM
- Form 4 Russillo Thomas R For: Aug 13 (10K)
Aug 13, 2009 06:39 PM
- Form 4 MUNRO GORDON For: Aug 12 (10K)
Aug 13, 2009 06:36 PM
- Form 4 WATSON PHARMACEUTICALS For: Aug 12 Filed by: MIRANDA DIANE F (10K)
Aug 13, 2009 06:35 PM
- Form 4 JOYCE R TODD For: Aug 12 (10K)
Aug 13, 2009 06:33 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
WPI
|
Compare to S&P
|
| YTD |
29.55 %
|
12.92 %
|
| 4 Weeks |
-3.53 %
|
-4.55 %
|
| 12 Weeks |
-0.12 %
|
-2.59 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 5.17 %
|
|
EPS Growth in Last Year: 27.08 %
|
|
Sales Growth in Last Quarter: 1.56 %
|
|
Sales Growth in Last Quarter: 8.86 %
|
|
